ANI Pharmaceuticals Inc - ANIP Operating Profitability

ANIP (ANI Pharmaceuticals Corp) - company brandmark

ANI Pharmaceuticals remains resilient to economic downturns due to the demand for essential medications. The company is betting on rare pathologies and complex generics for expansion. Operating profit margins are illustrated by this chart from the GURU.Markets system, where 15.30 represents the latest metric level. Growth relies on line automation and the search for new formulas within R&D.

ANIP: anipharmaceuticals.com Operating Profit Rate 07/04/2022 - 11/19/2026

anipharmaceuticals.com - analytical breakdowns and key metrics (ANIP)

- stock quotes and analyst forecast:
Comprehensive company analysis:ANI Pharmaceuticals Inc, ANIP
Core merchandise of ANI Pharmaceuticals

ANI Pharmaceuticals effectively combines the production of mass-market generics with the sale of high-cost orphan drugs, neutralizing price competition through exclusive niches. This indicator reflects the ratio of operating profit to revenue, demonstrating cost management efficiency and real business profitability, which allows the investor to assess the stability of the model through changes in core operating margins.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.